P
85.40
1.20 (1.43%)
| Penutupan Terdahulu | 84.20 |
| Buka | 84.24 |
| Jumlah Dagangan | 906,889 |
| Purata Dagangan (3B) | 1,199,557 |
| Modal Pasaran | 5,338,838,016 |
| Harga / Pendapatan (P/E TTM) | 129.39 |
| Harga / Pendapatan (P/E Ke hadapan) | 26.39 |
| Harga / Jualan (P/S) | 26.91 |
| Harga / Buku (P/B) | 8.50 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | 27.04% |
| Margin Operasi (TTM) | -68.18% |
| EPS Cair (TTM) | 0.780 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -88.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 381.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.65% |
| Nisbah Semasa (MRQ) | 17.25 |
| Aliran Tunai Operasi (OCF TTM) | 336.94 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 327.76 M |
| Pulangan Atas Aset (ROA TTM) | 2.48% |
| Pulangan Atas Ekuiti (ROE TTM) | 8.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Protagonist Therapeutics, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.50 |
|
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.10% |
| % Dimiliki oleh Institusi | 108.49% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 102.00 (Citizens, 19.44%) | Beli |
| Median | 86.00 (0.70%) | |
| Rendah | 73.00 (Leerink Partners, -14.52%) | Beli |
| Purata | 86.44 (1.22%) | |
| Jumlah | 9 Beli | |
| Harga Purata @ Panggilan | 75.73 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 10 Nov 2025 | 98.00 (14.75%) | Beli | 83.23 |
| 17 Oct 2025 | 96.00 (12.41%) | Beli | 77.50 | |
| Barclays | 07 Nov 2025 | 88.00 (3.04%) | Beli | 79.54 |
| 17 Sep 2025 | 72.00 (-15.69%) | Beli | 59.22 | |
| Citizens | 07 Nov 2025 | 102.00 (19.44%) | Beli | 79.54 |
| JP Morgan | 07 Nov 2025 | 81.00 (-5.15%) | Beli | 79.54 |
| BTIG | 28 Oct 2025 | 82.00 (-3.98%) | Beli | 78.51 |
| Truist Securities | 28 Oct 2025 | 88.00 (3.04%) | Beli | 78.51 |
| Wedbush | 28 Oct 2025 | 86.00 (0.70%) | Beli | 78.51 |
| HC Wainwright & Co. | 08 Oct 2025 | 80.00 (-6.32%) | Beli | 65.30 |
| 17 Sep 2025 | 80.00 (-6.32%) | Beli | 59.22 | |
| Leerink Partners | 12 Sep 2025 | 73.00 (-14.52%) | Beli | 58.86 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |